Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-24-029768
Filing Date
2024-09-20
Accepted
2024-09-20 16:45:05
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K inbp20240630_10k.htm   iXBRL 10-K 1205307
2 EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT ex_721278.htm EX-21 7144
3 EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_721279.htm EX-23.1 2815
4 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_721280.htm EX-31.1 20502
5 EXHIBIT 31.2 CERTIFICATION OF CFO ex_721281.htm EX-31.2 17671
6 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO SECTION 302 ex_721282.htm EX-32.1 8672
7 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT SECTION 302 ex_721283.htm EX-32.2 7059
  Complete submission text file 0001437749-24-029768.txt   6693998

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA inbp-20240630.xsd EX-101.SCH 58139
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20240630_cal.xml EX-101.CAL 46623
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20240630_def.xml EX-101.DEF 421756
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20240630_lab.xml EX-101.LAB 374972
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20240630_pre.xml EX-101.PRE 451724
76 EXTRACTED XBRL INSTANCE DOCUMENT inbp20240630_10k_htm.xml XML 1063780
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-31668 | Film No.: 241313903
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)